{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T06:47:53Z","timestamp":1790750873030,"version":"4.1.0"},"reference-count":78,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2020,8,26]],"date-time":"2020-08-26T00:00:00Z","timestamp":1598400000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,8,26]],"date-time":"2020-08-26T00:00:00Z","timestamp":1598400000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Rheumatol Rep"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1007\/s11926-020-00948-x","type":"journal-article","created":{"date-parts":[[2020,8,26]],"date-time":"2020-08-26T11:03:32Z","timestamp":1598439812000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":126,"title":["Pathogenesis of Giant Cell Arteritis and Takayasu Arteritis\u2014Similarities and Differences"],"prefix":"10.1007","volume":"22","author":[{"given":"Ryu","family":"Watanabe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerald J.","family":"Berry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David H.","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f6rg J.","family":"Goronzy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cornelia M.","family":"Weyand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,8,26]]},"reference":[{"key":"948_CR1","doi-asserted-by":"crossref","first-page":"5246","DOI":"10.4049\/jimmunol.179.8.5246","volume":"179","author":"MC Cuffy","year":"2007","unstructured":"Cuffy MC, Silverio AM, Qin L, Wang Y, Eid R, Brandacher G, et al. Induction of indoleamine 2,3-dioxygenase in vascular smooth muscle cells by interferon-gamma contributes to medial immunoprivilege. J Immunol. 2007;179:5246\u201354.","journal-title":"J Immunol"},{"key":"948_CR2","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1056\/NEJMra022694","volume":"349","author":"CM Weyand","year":"2003","unstructured":"Weyand CM, Goronzy JJ. Medium- and large-vessel vasculitis. N Engl J Med. 2003;349:160\u20139.","journal-title":"N Engl J Med"},{"key":"948_CR3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/art.37715","volume":"65","author":"JC Jennette","year":"2013","unstructured":"Jennette JC, Falk RJ, Bacon PA, Basu N, Cid MC, Ferrario F, et al. 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum. 2013;65:1\u201311.","journal-title":"Arthritis Rheum"},{"key":"948_CR4","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/nrrheum.2013.161","volume":"9","author":"CM Weyand","year":"2013","unstructured":"Weyand CM, Goronzy JJ. Immune mechanisms in medium and large-vessel vasculitis. Nat Rev Rheumatol. 2013;9:731\u201340.","journal-title":"Nat Rev Rheumatol"},{"issue":"Suppl 1","key":"948_CR5","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/1756-185X.13288","volume":"22","author":"TA Kermani","year":"2019","unstructured":"Kermani TA. Takayasu arteritis and giant cell arteritis: are they a spectrum of the same disease? Int J Rheum Dis. 2019;22(Suppl 1):41\u20138.","journal-title":"Int J Rheum Dis"},{"key":"948_CR6","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/1756-185X.12777","volume":"19","author":"M Yoshida","year":"2016","unstructured":"Yoshida M, Watanabe R, Ishii T, Machiyama T, Akita K, Fujita Y, et al. Retrospective analysis of 95 patients with large vessel vasculitis: a single center experience. Int J Rheum Dis. 2016;19:87\u201394.","journal-title":"Int J Rheum Dis"},{"key":"948_CR7","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1148\/radiol.13122195","volume":"270","author":"EJ Kang","year":"2014","unstructured":"Kang EJ, Kim SM, Choe YH, Lee GY, Lee KN, Kim DK. Takayasu arteritis: assessment of coronary arterial abnormalities with 128-section dual-source CT angiography of the coronary arteries and aorta. Radiology. 2014;270:74\u201381.","journal-title":"Radiology."},{"key":"948_CR8","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1161\/01.CIR.80.3.429","volume":"80","author":"R Subramanyan","year":"1989","unstructured":"Subramanyan R, Joy J, Balakrishnan KG. Natural history of aortoarteritis (Takayasu\u2019s disease). Circulation. 1989;80:429\u201337.","journal-title":"Circulation."},{"key":"948_CR9","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1161\/CIRCULATIONAHA.114.012547","volume":"132","author":"Y Watanabe","year":"2015","unstructured":"Watanabe Y, Miyata T, Tanemoto K. Current clinical features of new patients with Takayasu arteritis observed from cross-country research in Japan: age and sex specificity. Circulation. 2015;132:1701\u20139.","journal-title":"Circulation."},{"key":"948_CR10","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1007\/s12016-017-8612-9","volume":"53","author":"F Chasset","year":"2017","unstructured":"Chasset F, Frances C. Cutaneous manifestations of medium- and large-vessel vasculitis. Clin Rev Allergy Immunol. 2017;53:452\u201368.","journal-title":"Clin Rev Allergy Immunol"},{"key":"948_CR11","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1080\/14397595.2018.1546358","volume":"29","author":"H Yoshifuji","year":"2019","unstructured":"Yoshifuji H. Pathophysiology of large vessel vasculitis and utility of interleukin-6 inhibition therapy. Mod Rheumatol. 2019;29:287\u201393.","journal-title":"Mod Rheumatol"},{"key":"948_CR12","doi-asserted-by":"crossref","first-page":"372","DOI":"10.3109\/14397595.2013.854045","volume":"24","author":"R Watanabe","year":"2014","unstructured":"Watanabe R, Ishii T, Nakamura K, Shirai T, Fujii H, Saito S, et al. Ulcerative colitis is not a rare complication of Takayasu arteritis. Mod Rheumatol. 2014;24:372\u20133.","journal-title":"Mod Rheumatol"},{"key":"948_CR13","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1378\/chest.98.4.875","volume":"98","author":"JM Costello Jr","year":"1990","unstructured":"Costello JM Jr, Nicholson WJ. Severe aortic regurgitation as a late complication of temporal arteritis. Chest. 1990;98:875\u20137.","journal-title":"Chest."},{"key":"948_CR14","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1093\/rheumatology\/ker329","volume":"51","author":"A Ghinoi","year":"2012","unstructured":"Ghinoi A, Pipitone N, Nicolini A, Boiardi L, Silingardi M, Germano G, et al. Large-vessel involvement in recent-onset giant cell arteritis: a case-control colour-Doppler sonography study. Rheumatology (Oxford). 2012;51:730\u20134.","journal-title":"Rheumatology (Oxford)"},{"key":"948_CR15","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1002\/art.23577","volume":"59","author":"C Agard","year":"2008","unstructured":"Agard C, Barrier JH, Dupas B, Ponge T, Mahr A, Fradet G, et al. Aortic involvement in recent-onset giant cell (temporal) arteritis: a case-control prospective study using helical aortic computed tomodensitometric scan. Arthritis Rheum. 2008;59:670\u20136.","journal-title":"Arthritis Rheum"},{"key":"948_CR16","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1136\/annrheumdis-2011-200865","volume":"71","author":"S Prieto-Gonzalez","year":"2012","unstructured":"Prieto-Gonzalez S, Arguis P, Garcia-Martinez A, et al. Large vessel involvement in biopsy-proven giant cell arteritis: prospective study in 40 newly diagnosed patients using CT angiography. Ann Rheum Dis. 2012;71:1170\u20136.","journal-title":"Ann Rheum Dis"},{"key":"948_CR17","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.3899\/jrheum.151033","volume":"43","author":"M Saleh","year":"2016","unstructured":"Saleh M, Turesson C, Englund M, Merkel PA, Mohammad AJ. Visual complications in patients with biopsy-proven giant cell arteritis: a population-based study. J Rheumatol. 2016;43:1559\u201365.","journal-title":"J Rheumatol"},{"key":"948_CR18","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1093\/rheumatology\/kex397","volume":"57","author":"TA Kermani","year":"2018","unstructured":"Kermani TA, Sreih AG, Cuthbertson D, Carette S, Hoffman GS, Khalidi NA, et al. Evaluation of damage in giant cell arteritis. Rheumatology (Oxford). 2018;57:322\u20138.","journal-title":"Rheumatology (Oxford)"},{"key":"948_CR19","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1016\/j.ophtha.2016.05.008","volume":"123","author":"JJ Chen","year":"2016","unstructured":"Chen JJ, Leavitt JA, Fang C, Crowson CS, Matteson EL, Warrington KJ. Evaluating the incidence of arteritic ischemic optic neuropathy and other causes of vision loss from giant cell arteritis. Ophthalmology. 2016;123:1999\u20132003.","journal-title":"Ophthalmology."},{"key":"948_CR20","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1056\/NEJMcp1214825","volume":"371","author":"CM Weyand","year":"2014","unstructured":"Weyand CM, Goronzy JJ. Clinical practice. Giant-cell arteritis and polymyalgia rheumatica. N Engl J Med. 2014;371:50\u20137.","journal-title":"N Engl J Med"},{"key":"948_CR21","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.clim.2019.02.007","volume":"206","author":"CM Weyand","year":"2019","unstructured":"Weyand CM, Watanabe R, Zhang H, Akiyama M, Berry GJ, Goronzy JJ. Cytokines, growth factors and proteases in medium and large vessel vasculitis. Clin Immunol. 2019;206:33\u201341.","journal-title":"Clin Immunol"},{"key":"948_CR22","doi-asserted-by":"publisher","unstructured":"Gribbons KB, Ponte C, Carette S, et al. Patterns of arterial disease in Takayasu\u2019s arteritis and giant cell arteritis. Arthritis Care Res. 2019. https:\/\/doi.org\/10.1002\/acr.24055.","DOI":"10.1002\/acr.24055"},{"key":"948_CR23","doi-asserted-by":"publisher","unstructured":"Edwards SL, Baker V, Boswell GE, et al. A rare case of Takayasu arteritis with intracranial involvement, aortic valvulitis, and giant cell aortitis. J Clin Rheumatol. 2018; December 28, 2018 - Volume Publish Ahead of Print - Issue - https:\/\/doi.org\/10.1097\/RHU.0000000000000960.","DOI":"10.1097\/RHU.0000000000000960"},{"key":"948_CR24","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1016\/0046-8177(91)90015-H","volume":"22","author":"L Rushing","year":"1991","unstructured":"Rushing L, Schoen FJ, Hirsch A, Lie JT. Granulomatous aortic valvulitis associated with aortic insufficiency in Takayasu aortitis. Hum Pathol. 1991;22:1050\u20133.","journal-title":"Hum Pathol"},{"key":"948_CR25","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1097\/01.pas.0000213293.04026.ec","volume":"30","author":"DV Miller","year":"2006","unstructured":"Miller DV, Isotalo PA, Weyand CM, Edwards WD, Aubry MC, Tazelaar HD. Surgical pathology of noninfectious ascending aortitis: a study of 45 cases with emphasis on an isolated variant. Am J Surg Pathol. 2006;30:1150\u20138.","journal-title":"Am J Surg Pathol"},{"key":"948_CR26","doi-asserted-by":"crossref","first-page":"eaal3322","DOI":"10.1126\/scitranslmed.aal3322","volume":"9","author":"Z Wen","year":"2017","unstructured":"Wen Z, Shen Y, Berry G, Shahram F, Li Y, Watanabe R, et al. The microvascular niche instructs T cells in large vessel vasculitis via the VEGF-Jagged1-Notch pathway. Sci Transl Med. 2017;9:eaal3322.","journal-title":"Sci Transl Med"},{"key":"948_CR27","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1161\/CIRCRESAHA.118.313206","volume":"123","author":"R Watanabe","year":"2018","unstructured":"Watanabe R, Maeda T, Zhang H, Berry GJ, Zeisbrich M, Brockett R, et al. MMP (matrix metalloprotease)-9-producing monocytes enable T cells to invade the vessel wall and cause vasculitis. Circ Res. 2018;123:700\u201315.","journal-title":"Circ Res"},{"key":"948_CR28","doi-asserted-by":"crossref","first-page":"E970","DOI":"10.1073\/pnas.1616848114","volume":"114","author":"H Zhang","year":"2017","unstructured":"\u2022\u2022 Zhang H, Watanabe R, Berry GJ, et al. Immunoinhibitory checkpoint deficiency in medium and large vessel vasculitis. Proc Natl Acad Sci U S A. 2017;114:E970\u20139. This is the first report that patients with giant cell arteritis have a disease-relevant defect in the immunoinhibitory PD-1\/PD-L1 checkpoint.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"948_CR29","doi-asserted-by":"crossref","first-page":"H1052","DOI":"10.1152\/ajpheart.00024.2017","volume":"312","author":"R Watanabe","year":"2017","unstructured":"Watanabe R, Zhang H, Berry G, Goronzy JJ, Weyand CM. Immune checkpoint dysfunction in large and medium vessel vasculitis. Am J Physiol Heart Circ Physiol. 2017;312:H1052\u20139.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"948_CR30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.immuni.2013.07.012","volume":"39","author":"DS Chen","year":"2013","unstructured":"Chen DS, Mellman I. Oncology meets immunology: the cancer-immunity cycle. Immunity. 2013;39:1\u201310.","journal-title":"Immunity."},{"key":"948_CR31","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/nature21349","volume":"541","author":"DS Chen","year":"2017","unstructured":"Chen DS, Mellman I. Elements of cancer immunity and the cancer-immune set point. Nature. 2017;541:321\u201330.","journal-title":"Nature."},{"key":"948_CR32","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1056\/NEJMoa1200690","volume":"366","author":"SL Topalian","year":"2012","unstructured":"Topalian SL, Hodi FS, Brahmer JR, Gettinger SN, Smith DC, McDermott DF, et al. Safety, activity, and immune correlates of anti-PD-1 antibody in cancer. N Engl J Med. 2012;366:2443\u201354.","journal-title":"N Engl J Med"},{"key":"948_CR33","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1056\/NEJMoa1200694","volume":"366","author":"JR Brahmer","year":"2012","unstructured":"Brahmer JR, Tykodi SS, Chow LQ, et al. Safety and activity of anti-PD-L1 antibody in patients with advanced cancer. N Engl J Med. 2012;366:2455\u201365.","journal-title":"N Engl J Med"},{"key":"948_CR34","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1186\/s13075-019-1945-4","volume":"21","author":"LK Brekke","year":"2019","unstructured":"Brekke LK, Fevang BS, Diamantopoulos AP, et al. Survival and death causes of patients with giant cell arteritis in Western Norway 1972-2012: a retrospective cohort study. Arthritis Res Ther. 2019;21:154.","journal-title":"Arthritis Res Ther"},{"key":"948_CR35","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1016\/j.jacc.2019.01.049","volume":"73","author":"H Zhang","year":"2019","unstructured":"Zhang H, Watanabe R, Berry GJ, Nadler SG, Goronzy JJ, Weyand CM. CD28 signaling controls metabolic fitness of pathogenic T cells in medium and large vessel vasculitis. J Am Coll Cardiol. 2019;73:1811\u201323.","journal-title":"J Am Coll Cardiol"},{"key":"948_CR36","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1161\/CIRCULATIONAHA.117.030423","volume":"137","author":"H Zhang","year":"2018","unstructured":"Zhang H, Watanabe R, Berry GJ, Tian L, Goronzy JJ, Weyand CM. Inhibition of JAK-STAT signaling suppresses pathogenic immune responses in medium and large vessel vasculitis. Circulation. 2018;137:1934\u201348.","journal-title":"Circulation."},{"key":"948_CR37","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1038\/modpathol.2017.10","volume":"30","author":"JJ Maleszewski","year":"2017","unstructured":"Maleszewski JJ, Younge BR, Fritzlen JT, Hunder GG, Goronzy JJ, Warrington KJ, et al. Clinical and pathological evolution of giant cell arteritis: a prospective study of follow-up temporal artery biopsies in 40 treated patients. Mod Pathol. 2017;30:788\u201396.","journal-title":"Mod Pathol"},{"key":"948_CR38","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1172\/JCI84181","volume":"126","author":"Z Wen","year":"2016","unstructured":"Wen Z, Shimojima Y, Shirai T, Li Y, Ju J, Yang Z, et al. NADPH oxidase deficiency underlies dysfunction of aged CD8+ Tregs. J Clin Invest. 2016;126:1953\u201367.","journal-title":"J Clin Invest"},{"key":"948_CR39","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.4049\/jimmunol.1200122","volume":"189","author":"M Suzuki","year":"2012","unstructured":"Suzuki M, Jagger AL, Konya C, Shimojima Y, Pryshchep S, Goronzy JJ, et al. CD8+CD45RA+CCR7+FOXP3+ T cells with immunosuppressive properties: a novel subset of inducible human regulatory T cells. J Immunol. 2012;189:2118\u201330.","journal-title":"J Immunol"},{"key":"948_CR40","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/s41577-019-0180-1","volume":"19","author":"JJ Goronzy","year":"2019","unstructured":"Goronzy JJ, Weyand CM. Mechanisms underlying T cell ageing. Nat Rev Immunol. 2019;19:573\u201383.","journal-title":"Nat Rev Immunol"},{"key":"948_CR41","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1002\/JLB.1RI0418-160R","volume":"104","author":"JJ Goronzy","year":"2018","unstructured":"Goronzy JJ, Hu B, Kim C, Jadhav RR, Weyand CM. Epigenetics of T cell aging. J Leukoc Biol. 2018;104:691\u20139.","journal-title":"J Leukoc Biol"},{"key":"948_CR42","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.immuni.2017.03.010","volume":"46","author":"JJ Goronzy","year":"2017","unstructured":"Goronzy JJ, Weyand CM. Successful and maladaptive T cell aging. Immunity. 2017;46:364\u201378.","journal-title":"Immunity."},{"key":"948_CR43","doi-asserted-by":"crossref","unstructured":"Heath JJ, Grant MD. The immune response against human cytomegalovirus links cellular to systemic senescence. Cells. 2020;9:766.","DOI":"10.3390\/cells9030766"},{"key":"948_CR44","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s00430-019-00605-w","volume":"208","author":"M Jergovic","year":"2019","unstructured":"Jergovic M, Contreras NA, Nikolich-Zugich J. Impact of CMV upon immune aging: facts and fiction. Med Microbiol Immunol. 2019;208:263\u20139.","journal-title":"Med Microbiol Immunol"},{"key":"948_CR45","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1136\/annrheumdis-2012-201660","volume":"72","author":"C Dejaco","year":"2013","unstructured":"Dejaco C, Duftner C, Al-Massad J, et al. NKG2D stimulated T-cell autoreactivity in giant cell arteritis and polymyalgia rheumatica. Ann Rheum Dis. 2013;72:1852\u20139.","journal-title":"Ann Rheum Dis"},{"key":"948_CR46","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/BOR.0000000000000011","volume":"26","author":"CM Weyand","year":"2014","unstructured":"Weyand CM, Yang Z, Goronzy JJ. T-cell aging in rheumatoid arthritis. Curr Opin Rheumatol. 2014;26:93\u2013100.","journal-title":"Curr Opin Rheumatol"},{"key":"948_CR47","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/imr.12838","volume":"294","author":"CM Weyand","year":"2020","unstructured":"Weyand CM, Goronzy JJ. Immunometabolism in the development of rheumatoid arthritis. Immunol Rev. 2020;294:177\u201387.","journal-title":"Immunol Rev"},{"key":"948_CR48","doi-asserted-by":"crossref","unstructured":"\u2022\u2022 Watanabe R, Hilhorst M, Zhang H, et al. Glucose metabolism controls disease-specific signatures of macrophage effector functions. JCI Insight. 2018;3:e123047. This study defines a metabolic signature for macrophages in patients with giant cell arteritis, supporting the concept that pro-inflammatory macrophages could be re-educated through metabolic interference.","DOI":"10.1172\/jci.insight.123047"},{"key":"948_CR49","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1084\/jem.20150900","volume":"213","author":"T Shirai","year":"2016","unstructured":"Shirai T, Nazarewicz RR, Wallis BB, Yanes RE, Watanabe R, Hilhorst M, et al. The glycolytic enzyme PKM2 bridges metabolic and inflammatory dysfunction in coronary artery disease. J Exp Med. 2016;213:337\u201354.","journal-title":"J Exp Med"},{"key":"948_CR50","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.yjmcc.2015.01.021","volume":"89","author":"AJ Donato","year":"2015","unstructured":"Donato AJ, Morgan RG, Walker AE, Lesniewski LA. Cellular and molecular biology of aging endothelial cells. J Mol Cell Cardiol. 2015;89:122\u201335.","journal-title":"J Mol Cell Cardiol"},{"key":"948_CR51","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1111\/joim.12605","volume":"281","author":"M Tesauro","year":"2017","unstructured":"Tesauro M, Mauriello A, Rovella V, Annicchiarico-Petruzzelli M, Cardillo C, Melino G, et al. Arterial ageing: from endothelial dysfunction to vascular calcification. J Intern Med. 2017;281:471\u201382.","journal-title":"J Intern Med"},{"key":"948_CR52","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1161\/CIRCULATIONAHA.109.872903","volume":"121","author":"J Deng","year":"2010","unstructured":"Deng J, Younge BR, Olshen RA, Goronzy J\u0308J, Weyand CM. Th17 and Th1 T-cell responses in giant cell arteritis. Circulation. 2010;121:906\u201315.","journal-title":"Circulation."},{"key":"948_CR53","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1002\/art.39037","volume":"67","author":"D Saadoun","year":"2015","unstructured":"Saadoun D, Garrido M, Comarmond C, Desbois AC, Domont F, Savey L, et al. Th1 and Th17 cytokines drive inflammation in Takayasu arteritis. Arthritis Rheum. 2015;67:1353\u201360.","journal-title":"Arthritis Rheum"},{"key":"948_CR54","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.ajhg.2013.05.024","volume":"93","author":"C Terao","year":"2013","unstructured":"Terao C, Yoshifuji H, Kimura A, Matsumura T, Ohmura K, Takahashi M, et al. Two susceptibility loci to Takayasu arteritis reveal a synergistic role of the IL12B and HLA-B regions in a Japanese population. Am J Hum Genet. 2013;93:289\u201397.","journal-title":"Am J Hum Genet"},{"key":"948_CR55","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1186\/s13075-017-1408-8","volume":"19","author":"T Nakajima","year":"2017","unstructured":"Nakajima T, Yoshifuji H, Shimizu M, Kitagori K, Murakami K, Nakashima R, et al. A novel susceptibility locus in the IL12B region is associated with the pathophysiology of Takayasu arteritis through IL-12p40 and IL-12p70 production. Arthritis Res Ther. 2017;19:197.","journal-title":"Arthritis Res Ther"},{"key":"948_CR56","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.jbspin.2016.07.005","volume":"84","author":"R Watanabe","year":"2017","unstructured":"Watanabe R, Hosgur E, Zhang H, Wen Z, Berry G, Goronzy JJ, et al. Pro-inflammatory and anti-inflammatory T cells in giant cell arteritis. Joint Bone Spine. 2017;84:421\u20136.","journal-title":"Joint Bone Spine"},{"key":"948_CR57","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1172\/JCI117029","volume":"93","author":"Y Seko","year":"1994","unstructured":"Seko Y, Minota S, Kawasaki A, Shinkai Y, Maeda K, Yagita H, et al. Perforin-secreting killer cell infiltration and expression of a 65-kD heat-shock protein in aortic tissue of patients with Takayasu\u2019s arteritis. J Clin Invest. 1994;93:750\u20138.","journal-title":"J Clin Invest"},{"key":"948_CR58","doi-asserted-by":"crossref","first-page":"13045","DOI":"10.1073\/pnas.1808850115","volume":"115","author":"C Terao","year":"2018","unstructured":"Terao C, Yoshifuji H, Matsumura T, Naruse TK, Ishii T, Nakaoka Y, et al. Genetic determinants and an epistasis of LILRA3 and HLA-B*52 in Takayasu arteritis. Proc Natl Acad Sci U S A. 2018;115:13045\u201350.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"948_CR59","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1080\/14397595.2019.1570999","volume":"29","author":"A Kurata","year":"2019","unstructured":"Kurata A, Saito A, Hashimoto H, Fujita K, Ohno SI, Kamma H, et al. Difference in immunohistochemical characteristics between Takayasu arteritis and giant cell arteritis: it may be better to distinguish them in the same age. Mod Rheumatol. 2019;29:992\u20131001.","journal-title":"Mod Rheumatol"},{"key":"948_CR60","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1186\/s13075-019-2068-7","volume":"21","author":"K Matsumoto","year":"2019","unstructured":"Matsumoto K, Suzuki K, Yoshimoto K, Seki N, Tsujimoto H, Chiba K, et al. Significant association between clinical characteristics and changes in peripheral immuno-phenotype in large vessel vasculitis. Arthritis Res Ther. 2019;21:304.","journal-title":"Arthritis Res Ther"},{"key":"948_CR61","first-page":"61","volume":"11","author":"E De Smit","year":"2018","unstructured":"De Smit E, Lukowski SW, Anderson L, et al. Longitudinal expression profiling of CD4+ and CD8+ cells in patients with active to quiescent giant cell arteritis. BMC Med Genet. 2018;11:61.","journal-title":"BMC Med Genet"},{"key":"948_CR62","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1002\/art.41084","volume":"72","author":"J Zhang","year":"2020","unstructured":"Zhang J, Zhao L, Wang J, Cheng Z, Sun M, Zhao J, et al. Targeting mechanistic target of rapamycin complex 1 restricts proinflammatory T cell differentiation and ameliorates Takayasu arteritis. Arthritis Rheum. 2020;72:303\u201315.","journal-title":"Arthritis Rheum"},{"key":"948_CR63","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1002\/art.41198","volume":"72","author":"R Watanabe","year":"2020","unstructured":"Watanabe R. CD4+ T cells as key players in the immunopathology of Takayasu arteritis: comment on the article by. Arthritis Rheum. 2020;72:696\u20137.","journal-title":"Arthritis Rheum"},{"key":"948_CR64","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.autrev.2011.08.001","volume":"11","author":"L Arnaud","year":"2011","unstructured":"Arnaud L, Haroche J, Mathian A, Gorochov G, Amoura Z. Pathogenesis of Takayasu\u2019s arteritis: a 2011 update. Autoimmun Rev. 2011;11:61\u20137.","journal-title":"Autoimmun Rev"},{"key":"948_CR65","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1038\/s41467-020-15088-0","volume":"11","author":"T Mutoh","year":"2020","unstructured":"\u2022\u2022 Mutoh T, Shirai T, Ishii T, et al. Identification of two major autoantigens negatively regulating endothelial activation in Takayasu arteritis. Nat Commun. 2020;11:1253. This study has identified endothelial protein C receptor (EPCR) and scavenger receptor class B type 1 (SR-BI) as autoantigens on endothelial cells in patients with Takayasu arteritis. Bound autoantibodies promote inflammation by blocking the negative regulatory role of the two receptors.","journal-title":"Nat Commun"},{"key":"948_CR66","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1093\/rheumatology\/kex249","volume":"57","author":"G Pazzola","year":"2018","unstructured":"Pazzola G, Muratore F, Pipitone N, Crescentini F, Cacoub P, Boiardi L, et al. Rituximab therapy for Takayasu arteritis: a seven patients experience and a review of the literature. Rheumatology (Oxford). 2018;57:1151\u20135.","journal-title":"Rheumatology (Oxford)"},{"key":"948_CR67","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1536\/ihj.16-029","volume":"57","author":"FD Ramirez","year":"2016","unstructured":"Ramirez FD, Jamison BM, Hibbert B. Infectious aortitis. Int Heart J. 2016;57:645\u20138.","journal-title":"Int Heart J"},{"key":"948_CR68","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.vph.2015.11.084","volume":"80","author":"E Bossone","year":"2016","unstructured":"Bossone E, Pluchinotta FR, Andreas M, Blanc P, Citro R, Limongelli G, et al. Aortitis. Vasc Pharmacol. 2016;80:1\u201310.","journal-title":"Vasc Pharmacol"},{"key":"948_CR69","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s00296-018-4157-3","volume":"39","author":"G Keser","year":"2019","unstructured":"Keser G, Aksu K. Diagnosis and differential diagnosis of large-vessel vasculitides. Rheumatol Int. 2019;39:169\u201385.","journal-title":"Rheumatol Int"},{"key":"948_CR70","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1172\/JCI130730","volume":"130","author":"CJ Bowen","year":"2020","unstructured":"Bowen CJ, Calderon Giadrosic JF, Burger Z, et al. Targetable cellular signaling events mediate vascular pathology in vascular Ehlers-Danlos syndrome. J Clin Invest. 2020;130:686\u201398.","journal-title":"J Clin Invest"},{"key":"948_CR71","doi-asserted-by":"crossref","first-page":"72","DOI":"10.3400\/avd.ra.18-00012","volume":"11","author":"F Kasashima","year":"2018","unstructured":"Kasashima F, Kawakami K, Matsumoto Y, Endo M, Kasashima S, Kawashima A. IgG4-related arterial disease. Ann Vasc Dis. 2018;11:72\u20137.","journal-title":"Ann Vasc Dis"},{"key":"948_CR72","doi-asserted-by":"crossref","first-page":"102354","DOI":"10.1016\/j.autrev.2019.102354","volume":"18","author":"M Akiyama","year":"2019","unstructured":"Akiyama M, Kaneko Y, Takeuchi T. Characteristics and prognosis of IgG4-related periaortitis\/periarteritis: a systematic literature review. Autoimmun Rev. 2019;18:102354.","journal-title":"Autoimmun Rev"},{"key":"948_CR73","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.cyto.2019.02.013","volume":"119","author":"Y Oshima","year":"2019","unstructured":"Oshima Y, Takahashi S, Tani K, Tojo A. Granulocyte colony-stimulating factor-associated aortitis in the Japanese Adverse Drug Event Report database. Cytokine. 2019;119:47\u201351.","journal-title":"Cytokine."},{"key":"948_CR74","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.autrev.2018.12.011","volume":"18","author":"I Parodis","year":"2019","unstructured":"Parodis I, Dani L, Notarnicola A, Martenhed G, Fernstr\u00f6m P, Matikas A, et al. G-CSF-induced aortitis: two cases and review of the literature. Autoimmun Rev. 2019;18:615\u201320.","journal-title":"Autoimmun Rev"},{"key":"948_CR75","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1016\/S1470-2045(18)30608-9","volume":"19","author":"JE Salem","year":"2018","unstructured":"Salem JE, Manouchehri A, Moey M, Lebrun-Vignes B, Bastarache L, Pariente A, et al. Cardiovascular toxicities associated with immune checkpoint inhibitors: an observational, retrospective, pharmacovigilance study. Lancet Oncol. 2018;19:1579\u201389.","journal-title":"Lancet Oncol"},{"key":"948_CR76","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1002\/art.38282","volume":"66","author":"BL Goldstein","year":"2014","unstructured":"Goldstein BL, Gedmintas L, Todd DJ. Drug-associated polymyalgia rheumatica\/giant cell arteritis occurring in two patients after treatment with ipilimumab, an antagonist of ctla-4. Arthritis Rheum. 2014;66:768\u20139.","journal-title":"Arthritis Rheum"},{"key":"948_CR77","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.1007\/s10067-018-4177-0","volume":"37","author":"A Daxini","year":"2018","unstructured":"Daxini A, Cronin K, Sreih AG. Vasculitis associated with immune checkpoint inhibitors-a systematic review. Clin Rheumatol. 2018;37:2579\u201384.","journal-title":"Clin Rheumatol"},{"key":"948_CR78","doi-asserted-by":"publisher","unstructured":"Roy AK, Tathireddy HR, Roy M. Aftermath of induced inflammation: acute periaortitis due to nivolumab therapy. BMJ Case Rep. 2017. https:\/\/doi.org\/10.1136\/bcr-2017-221852.","DOI":"10.1136\/bcr-2017-221852"}],"container-title":["Current Rheumatology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-020-00948-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11926-020-00948-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-020-00948-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,25]],"date-time":"2021-08-25T19:13:57Z","timestamp":1629918837000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11926-020-00948-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,26]]},"references-count":78,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["948"],"URL":"https:\/\/doi.org\/10.1007\/s11926-020-00948-x","relation":{},"ISSN":["1523-3774","1534-6307"],"issn-type":[{"value":"1523-3774","type":"print"},{"value":"1534-6307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,26]]},"assertion":[{"value":"26 August 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors have declared that no conflict of interest exists.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}},{"value":"The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclaimer"}}],"article-number":"68"}}